{"transactions":[{"id":748057,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:05:08.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":19676,"derivative":{"exercise_price":29.55,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19676},"source":{"system":"sec-edgar","filing":"0001193125-26-259536","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526259536/ownership.xml","form_type":"4"}},{"id":1119720,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:28.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083055","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083055/ownership.xml","form_type":"4"}},{"id":1486913,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:42:12.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":23114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":23114,"derivative":{"exercise_price":24.49,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":23114},"source":{"system":"sec-edgar","filing":"0000950170-24-070766","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024070766/ownership.xml","form_type":"4"}},{"id":1862493,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:51:30.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":16532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":16532,"derivative":{"exercise_price":34.33,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":16532},"source":{"system":"sec-edgar","filing":"0000950170-23-027045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023027045/ownership.xml","form_type":"4"}},{"id":2167655,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-02T20:05:22.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":10391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":10391,"derivative":{"exercise_price":55.58,"expiration_date":"2032-09-01","underlying":"Common Stock","underlying_shares":10391},"source":{"system":"sec-edgar","filing":"0000899243-22-030270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924322030270/doc4.xml","form_type":"4"}},{"id":2670306,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T12:02:29.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":6877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":6877,"derivative":{"exercise_price":87.91,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":6877},"source":{"system":"sec-edgar","filing":"0000899243-21-023471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321023471/doc4.xml","form_type":"4"}},{"id":3279906,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-2 Preferred Stock","published_at":"2020-02-11T14:06:16.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":1239,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1239},"source":{"system":"sec-edgar","filing":"0000899243-20-003934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924320003934/doc4.xml","form_type":"4"}},{"id":3279905,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2020-02-11T14:06:16.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":15768,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15768},"source":{"system":"sec-edgar","filing":"0000899243-20-003934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924320003934/doc4.xml","form_type":"4"}},{"id":3279904,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":40949,"kind":"person","name":"Fishman Mark","position":1,"cik":"0001786003","reported_name":"Fishman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-11T14:06:16.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":17007,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock."}],"balance_after":17007,"source":{"system":"sec-edgar","filing":"0000899243-20-003934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924320003934/doc4.xml","form_type":"4"}}]}